𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Evaluation of adipose-derived stromal vascular fraction or bone marrow-derived mesenchymal stem cells for treatment of osteoarthritis

✍ Scribed by David D. Frisbie; John D. Kisiday; Chris E. Kawcak; Natasha M. Werpy; C. Wayne McIlwraith

Publisher
Elsevier Science
Year
2009
Tongue
English
Weight
161 KB
Volume
27
Category
Article
ISSN
0736-0266

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

The purpose of this study was the assessment of clinical, biochemical, and histologic effects of intraarticular administered adipose‐derived stromal vascular fraction or bone marrow‐derived mesenchymal stem cells for treatment of osteoarthritis. Osteoarthritis was induced arthroscopically in the middle carpal joint of all horses, the contralateral joint being sham‐operated. All horses received treatment on Day 14. Eight horses received placebo treatment and eight horses received adipose‐derived stromal vascular fraction in their osteoarthritis‐affected joint. The final eight horses were treated the in osteoarthritis‐affected joint with bone marrow‐derived mesenchymal stem cells. Evaluations included clinical, radiographic, synovial fluid analysis, gross, histologic, histochemical, and biochemical evaluations. No adverse treatment‐related events were observed. The model induced a significant change in all but two parameters, no significant treatment effects were demonstrated, with the exception of improvement in synovial fluid effusion PGE2 levels with bone marrow‐derived mesenchymal stem cells when compared to placebo. A greater improvement was seen with bone marrow‐derived mesenchymal stem cells when compared to adipose‐derived stromal vascular fraction and placebo treatment. Overall, the findings of this study were not significant enough to recommend the use of stem cells for the treatment of osteoarthritis represented in this model. © 2009 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 27:1675–1680, 2009

📜 SIMILAR VOLUMES

Biologic properties of mesenchymal stem
Biologic properties of mesenchymal stem cells derived from bone marrow and adipose tissue
✍ Reza Izadpanah; Cynthia Trygg; Bindiya Patel; Christopher Kriedt; Jason Dufour; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 377 KB 👁 2 views

## Abstract The biologic characteristics of mesenchymal stem cells (MSCs) isolated from two distinct tissues, bone marrow and adipose tissue were evaluated in these studies. MSCs derived from human and non‐human primate (rhesus monkey) tissue sources were compared. The data indicate that MSCs isola

Induction of fracture repair by mesenchy
Induction of fracture repair by mesenchymal cells derived from human embryonic stem cells or bone marrow
✍ Anita Undale; Daniel Fraser; Theresa Hefferan; Ross A. Kopher; James Herrick; Gl 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 419 KB 👁 1 views

## Abstract Development of novel therapeutic approaches to repair fracture non‐unions remains a critical clinical necessity. We evaluated the capacity of human embryonic stem cell (hESC)‐derived mesenchymal stem/stromal cells (MSCs) to induce healing in a fracture non‐union model in rats. In additi

Cellular senescence and longevity of ost
Cellular senescence and longevity of osteophyte-derived mesenchymal stem cells compared to patient-matched bone marrow stromal cells
✍ Sanjleena Singh; Navdeep Dhaliwal; Ross Crawford; Yin Xiao 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 456 KB 👁 1 views

## Abstract This study aimed to determine the cellular aging of osteophyte‐derived mesenchymal cells (oMSCs) in comparison to patient‐matched bone marrow stromal cells (bMSCs). Extensive expansion of the cell cultures was performed and early and late passage cells (passages 4 and 9, respectively) w

Adenoviral expression of vascular endoth
Adenoviral expression of vascular endothelial growth factor splice variants differentially regulate bone marrow-derived mesenchymal stem cells
✍ Huey Lin; Arsalan Shabbir; Merced Molnar; Jingwei Yang; Susan Marion; John M. Ca 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 423 KB

## Abstract Bone marrow‐derived mesenchymal stem cells (MSCs) are being explored for clinical applications, and genetic engineering represents a useful strategy for boosting the therapeutic potency of MSCs. Vascular endothelial growth factor (VEGF)‐based gene therapy protocols have been used to tre

Cartilage-like gene expression in differ
Cartilage-like gene expression in differentiated human stem cell spheroids: A comparison of bone marrow–derived and adipose tissue–derived stromal cells
✍ Anja Winter; Stephen Breit; Dominik Parsch; Karin Benz; Eric Steck; Hans Hauner; 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 342 KB 👁 2 views

## Abstract ## Objective To compare the chondrogenic potential of human bone marrow–derived mesenchymal stem cells (BMSC) and adipose tissue–derived stromal cells (ATSC), because the availability of an unlimited cell source replacing human chondrocytes could be strongly beneficial for cell therapy